|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Oversikt over luftvegsprøver, Mikrobiologisk
avdeling, HUS. |
2020-2021 |
|
|
Inneliggjande pasientar |
Veke 21-36 |
|
Veke 21-35 |
|
Veke 21-34 |
|
Veke 21-33 |
|
|
Totalt |
Påvist |
|
Totalt |
Påvist |
|
Totalt |
Påvist |
|
Totalt |
Påvist |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Bordetella pertussis |
150 |
<5 |
|
|
145 |
<5 |
|
|
131 |
<5 |
|
|
120 |
<5 |
|
|
|
Bordetella parapertussis |
150 |
<5 |
|
|
145 |
<5 |
|
|
131 |
<5 |
|
|
120 |
<5 |
|
|
|
Mycoplasma pneumoniae |
150 |
<5 |
|
|
145 |
<5 |
|
|
131 |
<5 |
|
|
120 |
<5 |
|
|
|
Chlamydia pneumoniae |
150 |
<5 |
|
|
145 |
<5 |
|
|
131 |
<5 |
|
|
120 |
<5 |
|
|
|
Influensavirus A |
419 |
<5 |
|
|
389 |
<5 |
|
|
444 |
<5 |
|
|
439 |
<5 |
|
|
|
Influensavirus B |
419 |
<5 |
|
|
389 |
<5 |
|
|
444 |
<5 |
|
|
439 |
<5 |
|
|
|
Parainfluensavirus 1 |
150 |
<5 |
|
|
145 |
<5 |
|
|
131 |
<5 |
|
|
120 |
<5 |
|
|
|
Parainfluensavirus 2 |
150 |
<5 |
|
|
145 |
<5 |
|
|
131 |
<5 |
|
|
120 |
<5 |
|
|
|
Parainfluensavirus 3 |
150 |
6 |
4 % |
|
145 |
7 |
5 % |
|
131 |
<5 |
|
|
120 |
<5 |
|
|
|
Respiratorisk syncytialt virus |
274 |
<5 |
|
|
247 |
<5 |
|
|
223 |
<5 |
|
|
224 |
<5 |
|
|
|
Humant metapneumovirus |
150 |
<5 |
|
|
145 |
<5 |
|
|
131 |
<5 |
|
|
120 |
<5 |
|
|
|
Rhinovirus |
150 |
13 |
9 % |
|
145 |
22 |
15 % |
|
131 |
15 |
11 % |
|
120 |
5 |
4 % |
|
|
SARS-CoV-2 |
499 |
<5 |
|
|
498 |
6 |
1 % |
|
582 |
7 |
1 % |
|
523 |
8 |
2 % |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Ambulante pasientar |
Veke 21-36 |
|
Veke 21-35 |
|
Veke 21-34 |
|
Veke 21-33 |
|
|
Totalt |
Påvist |
|
Totalt |
Påvist |
|
Totalt |
Påvist |
|
Totalt |
Påvist |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Bordetella pertussis |
402 |
<5 |
|
|
358 |
<5 |
|
|
256 |
<5 |
|
|
190 |
<5 |
|
|
|
Bordetella parapertussis |
402 |
<5 |
|
|
358 |
<5 |
|
|
256 |
<5 |
|
|
190 |
<5 |
|
|
|
Mycoplasma pneumoniae |
402 |
<5 |
|
|
358 |
<5 |
|
|
256 |
<5 |
|
|
190 |
<5 |
|
|
|
Chlamydia pneumoniae |
402 |
<5 |
|
|
358 |
<5 |
|
|
256 |
<5 |
|
|
190 |
<5 |
|
|
|
Influensavirus A |
436 |
<5 |
|
|
373 |
<5 |
|
|
272 |
<5 |
|
|
204 |
<5 |
|
|
|
Influensavirus B |
436 |
<5 |
|
|
373 |
<5 |
|
|
272 |
<5 |
|
|
204 |
<5 |
|
|
|
Parainfluensavirus 1 |
402 |
<5 |
|
|
358 |
<5 |
|
|
256 |
<5 |
|
|
190 |
<5 |
|
|
|
Parainfluensavirus 2 |
402 |
<5 |
|
|
358 |
<5 |
|
|
256 |
<5 |
|
|
190 |
<5 |
|
|
|
Parainfluensavirus 3 |
402 |
61 |
15 % |
|
358 |
42 |
12 % |
|
256 |
27 |
11 % |
|
190 |
13 |
7 % |
|
|
Respiratorisk syncytialt virus |
416 |
17 |
4 % |
|
365 |
11 |
3 % |
|
270 |
<5 |
|
|
198 |
<5 |
|
|
|
Humant metapneumovirus |
402 |
<5 |
|
|
358 |
<5 |
|
|
256 |
<5 |
|
|
190 |
<5 |
|
|
|
Rhinovirus |
402 |
117 |
29 % |
|
358 |
116 |
32 % |
|
256 |
60 |
23 % |
|
190 |
32 |
17 % |
|
|
SARS-CoV-2 |
20459 |
382 |
2 % |
|
26623 |
592 |
2 % |
|
25782 |
926 |
4 % |
|
19527 |
637 |
3 % |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Inneliggjande pasientar omfatter fleire
sjukehus i vår region |
|
|
|
|
|
|
|
16.09.2021 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|